Reliance Life Sciences seeks approval for Phase I trial of its Covid vaccine candidate

The Subject Expert Committee (SEC), which advises the drug regulator on applications seeking approval for vaccines, new drugs and clinical trials, will review the application at a meeting on Thursday, people in the know told ET.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3yk01TI
via IFTTT